In which patient populations are low- to medium‑potency topical corticosteroids appropriate?

Low to Medium Potency Topical Corticosteroids: Appropriate Patient Populations

Low to medium potency topical corticosteroids (classes 5-7) are appropriate for geriatric patients with thin skin, as these patients have increased risk of skin atrophy and adverse effects due to age-related skin changes and enhanced percutaneous absorption. 1, 2

Appropriate Populations for Low-Medium Potency Steroids

Geriatric Patients with Thin Skin ✓

• Elderly patients require lower potency corticosteroids due to age-related skin thinning and increased absorption risk. 2
• The face, neck, and intertriginous areas in elderly patients are particularly susceptible to steroid-induced atrophy and should be treated with class 6-7 (low potency) agents. 3, 1
• Geriatric patients have thinner skin on the forearms and other chronically sun-exposed areas, making these sites more prone to adverse effects from higher potency steroids. 3

Facial and Intertriginous Areas (All Ages)

• Low potency corticosteroids (classes 5-7) should be used on the face, genitals, and body folds due to increased absorption and atrophy risk in these anatomically sensitive sites. 3, 1
• Medium potency steroids (classes 3-5) can be used for longer treatment courses on non-sensitive body areas with a more favorable adverse event profile compared to high potency agents. 3

Pediatric Patients

• Children require lower potency agents due to higher risk of systemic absorption and adrenal suppression. 1, 4
• Class 6-7 corticosteroids have minimal risk of hypothalamic-pituitary-adrenal axis suppression in pediatric populations. 1

Inappropriate Populations for Low-Medium Potency Steroids

Keratotic Skin Lesions ✗

• Thick, chronic plaques with keratotic changes require ultra-high potency (class 1) corticosteroids, not low-medium potency agents. 3, 1
• Areas with thick plaques often need class 1 steroids like clobetasol propionate 0.05% to achieve adequate penetration and therapeutic effect. 3

Soles of the Feet ✗

• Palms and soles require high to ultra-high potency corticosteroids due to thick stratum corneum that limits drug penetration. 3
• Low-medium potency steroids are ineffective for plantar psoriasis and other conditions affecting the soles. 3

Patients with Steroid Tachyphylaxis History ✗

• The concept of true tachyphylaxis has been challenged—a 12-week study showed no patients exhibited receptor down-regulation with continuous topical corticosteroid use. 3
• Perceived "tachyphylaxis" is more likely due to poor patient adherence rather than actual receptor dysfunction. 3
• If inadequate response occurs, the solution is typically to increase potency or improve adherence, not to use lower potency agents. 3

Duration and Safety Guidelines

• Low potency corticosteroids (classes 6-7) have no specified time limit for use due to their favorable safety profile. 1, 4
• Medium potency steroids (classes 3-5) can be used for up to 12 weeks under careful supervision. 3
• Only 1% of 2,266 participants across 22 trials developed abnormal skin thinning, with just 2 cases reported with medium potency corticosteroids. 1